Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-01-01 @ 12:48 PM
Study NCT ID:
NCT05210868
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-01-27
First Post:
2021-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization: